Concepedia
Statistics
Publications
48
Citations
5.1K
H-Index
28
Active since
1993
Affiliations
Istanbul University(Current)
Erasmus MC
Ege University
Istanbul University-Cerrahpaşa
Goethe University Frankfurt
Yılmaz Çakaloğlu is an author at Istanbul University specializing in viral hepatitis, liver disease, and hepatology.
Publications per year
1993–2020
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
Harry L.A. Janssen, Monika van Zonneveld, Hakan Şentürk et al. · The Lancet · 2005 · 1.2K citations
Pharmacy, Pharmacology, Pharmacotherapy +15
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
Yun‐Fan Liaw, Edward Gane, Nancy Leung et al. · Gastroenterology · 2008 · 565 citations
Pharmacy, Pharmacology, Pharmacotherapy +14
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer, Cihan Yurdaydın, George Ν. Dalekos et al. · New England Journal of Medicine · 2011 · 474 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +13
Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b
Erik H.C.J. Buster, Hajo J. Flink, Yılmaz Çakaloğlu et al. · Gastroenterology · 2008 · 396 citations · Full text
Pharmacy, Infectious Diseases, Hepatitis Pharmacotherapy +2
Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study
Nurdan Tözün, Osman Özdoğan, Yılmaz Çakaloğlu et al. · Clinical Microbiology and Infection · 2015 · 292 citations · Full text
Veterinary Medicine, Infectious Diseases, Epidemiologic Methods +16
1–5 of 48